CLINICAL_TRIALS
trial_result
· 2024-08-05
Clinical Trial Update: Pharmacokinetic Evaluation of Intranasal Nalmefene Using Three Dosing Regimens [Phase 1]
Summary
Phase 1 pharmacokinetic study evaluating intranasal nalmefene across three dosing regimens.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Opiant Pharmaceuticals Inc | Conditions: Opioid Overdose | Phase 1 | Status: COMPLETED | Results posted: 2024-08-05